Max Robotics — Global Service Robot Directory + US Certification

About

Kevin P. Bateman is a leading figure in the integration of high-throughput chemistry and pharmacokinetics for drug discovery. His pioneering work centers on miniaturizing and automating complex chemical synthesis, most notably through the development of a nanomole-scale, high-throughput platform that enables rapid route scouting for drug candidates and natural products. This breakthrough, detailed in his highly cited 2014 paper (647 citations), has fundamentally accelerated early-stage discovery by allowing chemists to explore vast chemical space with minimal material. Bateman has also made significant contributions to pharmacokinetic (PK) analysis, championing the use of dried blood spots for discovery-stage PK studies (134 citations) and developing robotic sample preparation methods that reduce animal usage through serial bleeding in mice (51 citations). His work bridges the gap between synthetic chemistry and in vivo biology, providing practical, efficient tools that streamline the drug development pipeline. Bateman’s research is distinguished by its focus on practical, high-impact solutions—from automation to animal welfare—making him a key innovator in modern pharmaceutical research.